Schreglmann, S R <br/><br/>
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.  [electronic resource] 

 -  European journal of neurology  04 2017 
 - 545-551 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Equivalence Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1468-1331 
<br/><br/><label>Standard No.: </label>10.1111/ene.13260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Pressure--drug effects<br/>Cholinesterase Inhibitors--pharmacology<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Female<br/>Fludrocortisone--pharmacology<br/>Humans<br/>Hypotension, Orthostatic--complications<br/>Male<br/>Middle Aged<br/>Parkinson Disease--complications<br/>Pyridostigmine Bromide--pharmacology<br/>Quality of Life<br/>Risk Factors<br/>Treatment Outcome